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A commentary on
SPG7 is an essential and conserved component of the mitochondrial permeability transition
pore.
by Shanmughapriya, S., Rajan, S., Hoffman, N. E., Higgins, A. M., Tomar, D., Nemani, N., et al.
(2015). Mol. Cell 60, 47–62. doi: 10.1016/j.molcel.2015.08.009
SPG7 (paraplegin) is the product of the SPG7 gene, whose mutations are responsible for an
autosomal recessive form of hereditary spastic paraplegia (HSP) (De Michele et al., 1998). SPG7
is a AAA-protease (Casari et al., 1998) that co-assembles with a homologous protein, AFG3L, in
the inner mitochondrial membrane. These proteins associate with unidentified proteins in high
molecular weight complexes of up to 900 kDa, which are aberrant in HSP patient cells (Atorino
et al., 2003; Koppen et al., 2007). Loss of this complex following deletion of SPG7 causes decreased
activity of respiratory complex I and increased sensitivity to reactive oxygen species (ROS); both
events can be rescued by expression of SPG7 (Atorino et al., 2003). A recent paper suggests that
SPG7 also serves an essential role in the formation and regulation of themitochondrial permeability
transition pore (PTP) (Shanmughapriya et al., 2015).
The PTP is an inner membrane channel that forms after a permissive load of matrix Ca2+ under
conditions of oxidative stress (Bernardi, 2013; Bernardi et al., 2015). Strong evidence indicates
that it derives from the F-ATP synthase, which forms channels with electrophysiological features
matching those expected of the PTP in mammals (Giorgio et al., 2013; Alavian et al., 2014),
yeast (Carraro et al., 2014), and Drosophila (von Stockum et al., 2015). To identify regulators
of the PTP, Shanmughapriya et al. used a phenotypic screen based on the mitochondrial Ca2+
retention capacity (CRC) of digitonin-permeabilized cultured human cells after treatment with
siRNAs designed to suppress translation of a set of mitochondrial proteins (Shanmughapriya et al.,
2015). This assay (Murphy et al., 1996; Fontaine et al., 1998) is based on the assumption that the
CRC reflects the state of the PTP in situ, i.e. its propensity to open after treatment with Ca2+ and
PTP agonists. The screen identified 13 proteins whose suppression caused desensitization of the
PTP to Ca2+ with an increase of the CRC. The hits included well-known modulators that do not
take part in PTP formation like cyclophilin (CyP) D, the matrix receptor that mediates the PTP
inhibitory effect of cyclosporin A. The Authors identified SPG7 amongst the hits, and selected it
for further study because it could be co-immunoprecipitated with CyPD in a complex that also
included outer membrane VDAC1 (Shanmughapriya et al., 2015). Elimination of SPG7 expression
by Cas9/CRISPRmethods conferred protection fromCa2+- and oxidant-induced PTP opening and
from cell death, as expected based on PTP desensitization. The Authors conclude that SPG7 is an
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essential component of the PTP complex together with VDAC1,
but from analysis of the results we must conclude that this is
an overinterpretation that is not supported by the experimental
results presented.
First and foremost, the phenotypic screen does not allow a
distinction between core PTP components from regulators. This
difference–only core component of the PTP must necessarily
be essential to PTP formation while regulators may only
modulate PTP activity- represents important andmechanistically
discrete phenomena. Indeed, failure to appreciate this critical
difference has often confused our understanding of the molecular
composition of the PTP. In this study, the results show that the
PTP opened, albeit at higher Ca2+ loads, after suppression of
all 13 transcripts including SPG7 (Shanmughapriya et al., 2015).
Thus, the PTP opens even in the absence of SPG7, much as it
does in the absence of CyPD (Baines et al., 2005; Basso et al.,
2005; Nakagawa et al., 2005; Schinzel et al., 2005) questioning the
conclusion that the protein is an essential component of the pore.
Second, the mammalian PTP displays conductances up to 1.2 nS
(Szabo and Zoratti, 2014) that are unlikely to be generated by the
2-transmembrane domain proteins SPG7 and AFG3L. Indeed,
and in spite of its claims, the study of Shanmughapriya et al. does
not address the question of whether the putative “PTP complex”
formed by SPG7, AFG3L, andVDAC1 can actually form channels
at all. Thus, the graphical abstract depicting the PTP as a complex
of SPG7, AFG3L, and VDAC1 is a misrepresentation of the actual
findings of the paper and of the literature on the PTP. The
putative role of VDAC1 deserves a specific comment.
VDAC1 is the major outer membrane protein and one of
the most abundant mitochondrial proteins in mammals. Its
association with the PTP was suggested based on co-purification
with other putative components, i.e. the adenine nucleotide
translocase and the peripheral benzodiazepine receptor, today
called TSPO (McEnery et al., 1992). The link was made because
ligands of TSPO are also agonists of the PTP (Kinnally et al.,
1993). As shown by experiments on mitochondria from mice
where the corresponding genes were deleted, neither TSPO
(Šileikyte et al., 2014) nor VDAC1 (Krauskopf et al., 2006) is
an essential component of the PTP or a regulator of its activity,
and the effects of “TSPO ligands” on the pore could rather be
explained by their interaction with the F-ATP synthase (Cleary
et al., 2007; Giorgio et al., 2013). Of note, also genetic inactivation
of the less abundant VDAC2 and VDAC3 isoforms does not
affect PTP opening and PTP-dependent cell death (Baines et al.,
2007). Thus, the reported co-immunoprecipitation of SPG7 with
VDAC1 (Shanmughapriya et al., 2015) does not bear on the
nature or regulation of the PTP. Our comment does not imply
that the outer mitochondrial membrane does not regulate PTP
activity, as discussed in detail (Bernardi et al., 2015).
Surprisingly, Shanmughapriya et al. do not discuss possible
mechanisms through which SPG7 may regulate the PTP. We
suspect that the high molecular weight complex formed by SPG7
and AFG3L reported by Casari and coworkers (Atorino et al.,
2003; Koppen et al., 2007) may be due to a direct interaction of
the AAA-protease heterodimers with F-ATP synthase, whichmay
in turn stabilize dimers/oligomers of the complex and thus favor
Ca2+-dependent PTP formation (Bernardi et al., 2015). Increased
oxidative stress due to inhibition of complex I could easily explain
sensitization of the PTP. Thus, SPG7 could be one more of the
many regulators of the PTP, but not an essential component of
the pore.
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